Clinical trials are an essential part of the process that brings new drug therapies and cures to market, but Brown and Black people are severely underrepresented in this life-saving research. The problem dates back to misconduct in trials like Tuskegee and a subsequent lack of inclusion in later studies. Unfortunately, a host of stigmas and stereotypes have since become barriers to accessing quality healthcare. We must address the inherent mistrust and break down those barriers now, before it’s too late. In this episode, I talk with two dawgs from the International Myeloma Foundation: Dr. Joseph Mikhael, and President and CEO, Yelak Biru. Both are working tirelessly to educate and engage Brown and Black communities and bring essential diversity to clinical trials. It’s a heavy lift—it takes time to build trust—but the IMF is focused on the tools and connections that will make a difference. Join us as we delve into the critical role of clinical trials, specifically in underserved communities, and explore the factors driving reluctance to participate, along with actionable steps to overcome them. Our guests share personal insights and professional expertise on how to build trust and encourage greater participation. This episode is a must-listen for anyone interested in understanding the complexities and solutions surrounding clinical trials and healthcare disparities in underserved communities. Listen in and learn how you can help pave the way for a healthier future.